VSee Health, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 17, 2026, reporting condensed consolidated balance sheet figures that show a significant decline in cash and total assets compared to December 31, 2025.
Key Highlights
- Cash position: Cash stood at $41,666 as of September 30, 2026, down from $5,051,445 as of December 31, 2025, according to the filing.
- Total assets: The company reported total assets of $15,706,172 as of September 30, 2026, compared to $22,413,019 as of December 31, 2025.
- Accumulated deficit: The accumulated deficit reached $87,018,413 as of September 30, 2026, up from $82,416,723 as of December 31, 2025.
- Common shares outstanding: As of November 15, 2026, there were 876,837 shares of common stock outstanding; shares issued and outstanding on the balance sheet date were 806,078 as of September 30, 2026, versus 414,995 as of December 31, 2025.
- Allowance for credit losses: The allowance for credit losses on accounts receivable was $1,902,156 as of September 30, 2026, compared to $835,007 as of December 31, 2025.
- Convertible notes: Convertible notes totaled $1,429,660 as of September 30, 2026, up from $713,128 as of December 31, 2025.
- Company classification: The registrant identified itself as a non-accelerated filer, smaller reporting company, and emerging growth company.
VSee Health Balance Sheet Shows Asset Decline and Rising Deficit in September 2026 Quarter
VSee Health, Inc. (OTC:VSEE), a Delaware-incorporated company headquartered in Boca Raton, Florida, filed its quarterly report covering the period ended September 30, 2026. According to the filing, cash dropped sharply to $41,666 from $5,051,445 at year-end 2025. Total current assets declined to $2,815,312 from $8,365,407 over the same period, with the filing noting that current assets from discontinued operations, which had contributed $626,898 at December 31, 2025, carried a zero balance by September 30, 2026.
The filing reports total liabilities of $10,693,319 as of September 30, 2026, compared to $16,960,651 at December 31, 2025. Current liabilities fell to $9,585,883 from $16,244,608, in part because current liabilities from discontinued operations, which stood at $3,860,818 at year-end 2025, were eliminated by the quarter-end date. Accounts payable and accrued liabilities decreased to $7,429,784 from $9,330,442. A new SEPA liability of $206,663 appeared on the September 30, 2026 balance sheet with no comparable prior-period balance.
Total stockholders' equity was reported at $5,012,853 as of September 30, 2026, a decrease from $5,452,368 at December 31, 2025. The company reported goodwill of $4,916,694 and intangible assets, net, of $7,127,506 as of September 30, 2026. Series A Preferred stock had 122 shares issued and outstanding as of September 30, 2026, down from 1,788 shares at December 31, 2025. The filing contains forward-looking statements that the company notes are subject to its cautionary language and the risk factors described in its Annual Report on Form 10-K for the year ended December 31, 2025.
What Was Disclosed
VSee Health, Inc. filed a Form 10-Q for the quarter ended September 30, 2026, disclosing condensed consolidated balance sheet data showing reduced cash, lower total assets, a higher accumulated deficit, and changes in share counts and liability composition compared to December 31, 2025.



Please wait processing your request...